Companies / Lineage Cell Therapeutics, Inc. / Activity
Activity — Lineage Cell Therapeutics, Inc.
5 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Culley Brian M CEO | Other | Common Shares | $23.2K | -13K -5.08% | 240,516 0.10% of shares | low |
| Mar 12, 2026 | Culley Brian M CEO | Buy | Common Shares | $24.4K | +15K +6.24% | 255,516 0.10% of shares | low |
| Mar 5, 2026 | Culley Brian M CEO | Grant | Employee Stock Option (Right to Buy) | — | +3.3M | 3,250,000 1.29% of shares | low |
| Feb 11, 2026 | Culley Brian M CEO | Exercise | Restricted Stock Units | — | -31K -100.00% | 0 0.00% of shares | low |
| Feb 11, 2026 | Culley Brian M CEO | Exercise | Common Shares | — | +31K +14.07% | 253,385 0.10% of shares | low |